John Park - Concepedia

Author

John Park

Advocate Lutheran General Hospital ORCID

Also Known As

Dina Rosen, Hope Rugo, J J Park, J. J. Park, J.J. Park, JOHN J. PARK, JOHN PARK, Jin Joo Park, Jin Park, John J Park

459

Publications

14K

Citations

H-Index

259

Concepts

All Affiliations

Advocate Lutheran General Hospital University of Illinois Chicago The University of Sydney Melanoma Institute Australia Royal North Shore Hospital

About

John Park is an author at Advocate Lutheran General Hospital specializing in medicine, health sciences, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	11	11	379
2	Engineering	9	9	476
3	Education	4	4	312
4	Arts	1	1	229
5	Business	1	1	320

John Park

108

Publications

10.9K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma Teri Kreisl, Lyndon Kim, Kraig Moore, Journal of Clinical Oncology	2008	1.6K
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab Alexander M. Menzies, Douglas B. Johnson, Sangeetha Ramanujam, Annals of Oncology Autoimmune DisordersAutoimmune DiseaseAnti-pd-1 TherapyMelanomaImmunology	2016	811
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis Jennifer L. McQuade, Carrie R. Daniel, Kenneth R. Hess, The Lancet Oncology OncologyBody CompositionCancer ManagementMelanomaMetastatic Melanoma	2018	647
Meckel Diverticulum John Park, Bruce G. Wolff, Matthew K. Tollefson, Annals of Surgery	2005	606
A specific antidote for dabigatran: functional and structural characterization Felix Schiele, Joanne van Ryn, Keith A. Canada, Blood	2013	560
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Entrepreneurial Social Capital Alistair R. Anderson, John Park, Sarah Jack International Small Business Journal Researching Entrepreneurship Entrepreneurial PhenomenonSociologyManagementBusinessEntrepreneurship Research	2007	320
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Connecting Informal and Formal Learning Experiences in the Age of Participatory Media Glen Bull, Ann Thompson, Mike Searson, Contemporary issues in technology and teacher education Digital SocietyEducationContent CreationCommunicationOnline Learning Community	2008	229

Page 1